Genedrive PLC (LSE:GDR) - Overview

Stock Report

Genedrive PLC GDR

Last Price
GBX55.00

Day Change
-5.00|-8.33%

As of 06/12/2016
11:54:59 GMT | GBX
Minimum 15 Minutes Delay.

Last Close60.00p
Day Range55.00 - 55.00
Mkt Cap11.21Mil
52-Wk Range50.00 - 125.00
Yield %0.00
ISINGB00B1VKB244
Volume2,200
P/E-0.98
P/S1.14
P/CF-1.53

Share Price

Total Returns 05/12/2016

 Chg (%)  
More ...
Genedrive PLC-4.00 
FTSE 100 TR GBP1.22
 
Financials
201420152016
More ...
Income Statement
Turnover5.764.525.06
Operating Profit-2.30-4.04-5.43
Net Profit-1.69-3.03-5.92
Reported EPS-17.40-30.20-56.20
Balance Sheet
Current Assets6.847.974.87
Non Current Assets7.788.036.99
Total Assets14.6215.9911.86
Current Liabilities3.752.421.86
Total Liabilities3.756.458.10
Total Equity10.869.553.75
Cash Flow
Operating Cash Flow-1.67-4.82-4.19
Net Change in Cash-2.220.40-4.01
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017--34.10--1.76---
2018-2.60-23.08---

Regulatory News

DateSourceHeadline
More ...
30/11/2016|14:16RNSGenedrive PLC - Result of AGM
29/11/2016|07:00RNSGenedrive PLC - Update on CFO Appointment
11/11/2016|17:47RNSGenedrive PLC - Notice of AGM
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
12/07/2016SaleDr. Ian Gilham85.0031,25026,563.00
12/07/2016PurchaseDr. Ian Gilham85.0031,25026,563.00
12/07/2016PurchaseDr. Ian Gilham80.0031,25025,000.00
12/07/2016PurchaseMr. John Rylands80.00162,500130,000.00

Company Profile

Genedrive PLC is a molecular diagnostics company. It develops and commercialise a low cost, versatile point-of-need diagnostics platform for the diagnosis of infectious diseases, pathogen detection, patient stratification and other indications.
 

Sector

Diagnostics & Research

Market Position

1485 of 1864 Companies

Index

FTSE AIM All Share

Outlook

(11/11/2016) "...we are confident that we will deliver momentum in the roll out of our programmes during the coming financial year"

Next Event 31/03/2017

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)-3.2913.5916.10
Div Yld (E)0.004.234.35
PEG (E)0.000.550.19
ROCE-262.93209.79-30.25
Op Mrgn-129.19-15.64-33.57
EPS Grwth0.008.6822.86
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanDr. Ian Gilham
Chief Executive OfficerDavid Budd
Finance Director & Company SecretaryMr. John Rylands
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.